Fatty Liver Diseases

2,417
Total downloads
9,635
Total views and downloads

Articles

CLINICAL TRIAL

Published on 28 Jul 2022

A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes

Azam Doustmohammadian
Ahmad Nezhadisalami
Fahimeh Safarnezhad Tameshke
Nima Motamed
Mansooreh Maadi
Mohammad Farahmand
Masoudreza Sohrabi
Cain C. T. Clark
Hossein Ajdarkosh
4 more
Farhad Zamani

A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes

doi 10.3389/fmed.2022.937554

3,406 views
8 citations

ORIGINAL RESEARCH

Published on 31 Mar 2022

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease

Qing-Feng Sun
Liang-Jie Tang
Ming-Jie Wang
Pei-Wu Zhu
Yang-Yang Li
Hong-Lei Ma
Ou-Yang Huang
Liang Hong
Gang Li
5 more
Ming-Hua Zheng

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease

doi 10.3389/fmed.2022.864570

2,341 views
11 citations

ORIGINAL RESEARCH

Published on 23 Mar 2022

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease

Xuemei Tao
Lin Chen
Youfei Zhao
Yonggang Liu
Ruifang Shi
Bei Jiang
Yuqiang Mi
Liang Xu

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease

doi 10.3389/fmed.2022.862879

1,993 views
4 citations

Share on

Frontiers in Medicine

Frontiers in Medicine

Gastroenterology

Impact

9,635Topic views
6,354Article views
2,417Article downloads